Clinical Research
Hyundai Bioscience Partners with UC San Diego for Pioneering Long-COVID Clinical Trial of Antiviral Xafty®
Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an invest...
September 18, 2024 | News
Metabolon Launches Advanced Statistical Analysis Tool to Accelerate Multiomic Research
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...
September 18, 2024 | News
ImmVira Reports Promising Phase I Results for Oncolytic Virus MVR-T3011 in BCG-Failure Bladder Cancer
ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical administration in patients with high-risk B...
September 16, 2024 | News
Nona Biosciences and Umoja Biopharma Partner to Advance Next-Generation CAR-T Cell Therapies
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced that it has entered into a multi...
September 13, 2024 | News
Thermo Fisher Scientific Awards Oncomine Clinical Research Grants to Advance Global Oncology Diagnostics
Recipients’ research advances future development of oncology diagnostics, the impact of DNA quality on ovarian cancer outcomes and molecular diagnosi...
September 12, 2024 | News
HighTide Therapeutics Presents Promising Data on HTD1801 for Type 2 Diabetes at EASD 2024
HighTide Therapeutics, Inc. (2511.HK), a clinical-stage biopharmaceutical company dedicated to developing multifunctional therapies for chronic liver and m...
September 12, 2024 | News
Hyundai Bioscience Announces XAFTY®: A Breakthrough Broad-Spectrum Antiviral for COVID-19, Mpox, and Dengue
Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit 2024" held in Philadel...
September 12, 2024 | News
Avistone Biotechnology Presents Promising Clinical Results of Dual c-MET and EGFR Inhibitors for NSCLC at WCLC 2024
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision...
September 11, 2024 | News
MGI Introduces CycloneSEQ-WT02 and CycloneSEQ-WY01, Advancing High-Throughput Nanopore Sequencing
MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced the global r...
September 10, 2024 | Product Spotlight
Neurophet Expands Global Reach with AI Brain Imaging Partnership and Research Recognition
Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis Neurophet, an artificial intelligence (AI) solution ...
September 10, 2024 | News
Janssen-Cilag International Announces Superior Long-Term Outcomes of Amivantamab Plus Lazertinib from MARIPOSA Study
Janssen-Cilag International NV, a Johnson & Johnson company, announced new longer follow-up data from the landmark Phase 3 MARIPOSA study. These ...
September 09, 2024 | News
Daiichi Sankyo and AstraZeneca’s Datopotamab Deruxtecan Shows Superior Progression-Free Survival in Biomarker-Positive NSCLC Patients
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan demonstrated meaningfully greater magnitude of progression-free survival benefit in p...
September 09, 2024 | News
Merck Launches Global Phase III Trial of Oral Cladribine for Generalized Myasthenia Gravis Treatment
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG) Cl...
September 06, 2024 | News
Crucial Data Solutions Unveils AI-Powered Module to Revolutionize Clinical Trial Data Analysis
Crucial Data Solutions, a leading provider of data collection and trial management software to advance clinical research, has announced the launch of...
September 06, 2024 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
